Research

Where You Are:

Moffitt Cancer Center is one of 41 NCI-designated comprehensive cancer centers in the country and the only one based in Florida. The designation is bestowed upon institutions that have significant peer-reviewed research funding; high-quality programs in basic, translational and population research; are dedicated to developing more effective approaches to cancer prevention, diagnosis and therapy; educate health care professionals and the public; and reach out to underserved populations.

Moffitt's impact on cancer research spans basic science, prevention and clinical research with a focus on translating discoveries into better care.

Research Disciplines | Clinical Trials | Research Cores & Technology | Find a Researcher  | Conflict of Interest


Moffitt Research News

Moffitt Cancer Center Researchers Use Evolutionary Principles to Model Cancer Mutations, Discover Potential Therapeutic Targets

TAMPA, Fla. (Nov. 19, 2014) – Moffitt Cancer Center researchers are taking a unique approach to understanding and investigating cancer by utilizing evolutionary principles and computational modeling to examine the role of specific genetic mutations in the Darwinian struggle among tumor and normal cells during cancer growth. Learn more...

Moffitt Cancer Center Announces Development of Experimental Treatment for Myelodysplastic Syndromes, Autoimmune Diseases

TAMPA, Fla. (Nov. 17, 2014) – In a major step to treat patients living with Myelodysplastic Syndromes (MDS), a group of diseases that affect the bone marrow and blood, Moffitt Cancer Center announced the development of an innovative investigational biologic agent that could improve patient response and outcomes for MDS and other diseases. Learn more...

 

Moffitt Cancer Center Researchers Discover Common Chemotherapeutic Agent Reduces Resistance to Virus Therapy in Brain Tumor Patients

TAMPA, Fla. (Nov. 11, 2014) –  Moffitt Cancer Center researchers, in conjunction with colleagues at University of Calgary, have found that the common chemotherapeutic agent cyclophosphamide can help improve the success of oncolytic virus therapy in patients with malignant gliomas, a common type of brain tumor. Oncolytic virus therapy is an innovative therapeutic approach that uses viruses to target and kill cancer cells. The viruses can be modified to allow them to target specific cancer cells or to deliver therapy-modifying genes. Learn more... 
 
TOOLS:   Font Size small font resizer separator font resizer separator big font resizer
 |  Site Map  |  Privacy Policy  |  Terms and Conditions